Researchers seek to demystify the biology of aging
Chicago — Medical researchers in Chicago are studying the difference between a person's chronological age — how many years they've lived — and their biological age, how old their body actually is.
"We are in a place where the biology of aging has been demystified," said Dr. Douglas Vaughan, director of the Potocsnak Longevity Institute at the Northwestern University Feinberg School of Medicine in Chicago, and the head of the study. "...If we can slow down aging, just a little bit, we can push back the onset of disease, and we can give people a longer health span."
The foundation of Vaughan's research came from a small Amish community in Indiana, where he found that a genetic variation in about 10% of the population allows them to live, on average, a decade longer than those in their community.
"They can teach us a lot about what's required for healthy aging to take place," Vaughan said.
That work has evolved into an international examination of aging Vaughan leads at the Longevity Institute.
"As you get older, you want to know, like, am I going stay sharp," Vaughan said.
The Longevity Institute was established in 2022. Study participants undergo a one-time visit that lasts anywhere from 60 minutes to 3 hours, with follow-ups to provide updates on their health status.
"Being able to be a representative from minority community is really important because I wanna know, how does this information measure up to people like me?" study participant Kalinda Marshall said.
The researchers use a series of tests to calculate biological age, including a scan of the retina and an analysis of participants' physical movement.
They also measure body mass in a machine called a Bod Pod. They do an electrocardiogram for heart function. They then use artificial intelligence to scour the mountain of data to come up with a number for a participant's biological age.
"Artificial intelligence gives us the opportunity to find patterns in the data that we can't find with our eyes, that we can't detect with a human brain," said Dr. Josh Cheema, a cardiologist with Northwestern Medicine involved in the project.
The work has a special focus on people in marginalized communities and those living with long-term medical problems.
"We are really interested in finding out ways to slow down aging in people that are disadvantaged," Vaughan said.
A network of similar labs conducting the same research on three other continents is in the works, and there are already signs of progress. In trials, pills that mimic the genetic variation that helps Amish live longer has done the same thing for mice.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
4 days ago
- New York Post
Menopause drug might prevent breast cancer and treat hot flashes, research finds
A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, 'significantly reduced' breast tissue cell growth, which is a major indicator of cancer progression. Advertisement A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. Advertisement 'The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo,' Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. 5 New research from Northwestern University found that the drug Duavee 'significantly reduced' breast tissue cell growth, a major indicator of cancer progression. Marko Geber – Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. 'This would be expected, as the drug is FDA-approved to treat hot flashes.' Advertisement Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. 5 The women in the study were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Gorodenkoff – 5 Those who took the drug reported fewer hot flashes during the study. fizkes – The findings are preliminary and have not yet been published in a medical journal. Advertisement 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced 'high-risk lesions' — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. 'These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options,' the release stated. Study limitations The researchers said they are 'encouraged' by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. 'Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure,' Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. 5 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' Dr. Swati Kulkarni said. sarayutsridee – Advertisement 'While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk,' he told Fox News Digital. Kabraji also noted that the study focused on reducing levels of one specific protein, 'which does not always predict reduced recurrence of breast cancer.' 'This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer,' he noted. 5 According to Kulkarni,'larger studies with several years of follow-up are needed' to confirm that the drug prevents breast cancer. Science RF – Advertisement 'Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention.' Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. 'Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms,' she added.
Yahoo
6 days ago
- Yahoo
What we know about measles during pregancy
The death of an Ontario infant born prematurely and infected with measles through the mother is raising questions about how the virus is transmitted during pregnancy. On Thursday, Ontario health officials announced the death of a baby who was infected with the virus while in the womb. It was the first fatality in the provincial outbreak that began on Oct. 28 last year and includes 2,009 probable and confirmed cases. "While measles may have been a contributing factor in both the premature birth and death, the infant also faced other serious medical complications unrelated to the virus," Dr. Kieran Moore, Ontario's chief medical officer of health, said in a statement released Thursday. Measles is a respiratory infection with symptoms that include fever, a blotchy rash, a cough and red, watery eyes. In May 2024, a child under five died of measles in Hamilton, but before that, there were no measles deaths in the province in more than a decade. Moore has previously said the current outbreak was traced to a Mennonite wedding in New Brunswick, and is spreading primarily in Mennonite and Amish communities where vaccination rates lag. The majority of those cases are in southwestern Ontario. Health officials stress that anyone who isn't vaccinated is vulnerable to measles and they encourage everyone to ensure they are up to date on their Measles, Mumps and Rubella (MMR) vaccines. "I urge everyone, but especially those who may become pregnant, to ensure they have received two doses of the MMR vaccine, which will protect both a parent and baby," said Moore. What is known about measles transmission during pregnancy? Dr. Jacqueline Wong, a pediatric infectious diseases specialist at McMaster Children's Hospital, says transmission of measles during pregnancy is rare. If the baby does contract measles from the mother in utero, Wong says the impact varies depending on how far along the pregnancy is. "Your risk of transmitting the infection to the baby varies during the different trimesters because of the development of the fetus, the development of the placenta and the blood flow." What are the risks during pregnancy? Dr. Sheryl Choo, a maternal-fetal medicine specialist at Royal Alexandra Hospital in Edmonton, says there are serious complications that can result if people who are pregnant become infected with measles. For instance, she says pregnant people infected with measles can develop lung infections like pneumonia at almost double the rate of those who are not pregnant. If people become infected with measles during pregnancy, Choo notes it can also increase the risk of serious complications including miscarriage and premature birth. According to Moore, the MMR vaccine has been safely used for over 50 years and is highly effective. "Two doses provide nearly 100 per cent protection," he said in a statement Thursday. What about risks to the baby? Babies born to those infected with measles can face complications related to premature birth, such as low birth weight and breathing issues, which can result in stays in the neonatal intensive care unit, Choo said. This is all on top of the symptoms of a measles infection itself, she said. Much rarer complications of measles can include subacute sclerosing panencephalitis, or SSPE. It is almost always fatal and generally develops seven to 10 years after an initial measles infection, even if the person appears to have fully recovered. It can be dormant in the brain for years and may eventually flare up, causing brain inflammation and resulting in children or young adults losing the ability to move and speak. According to the Public Health Agency of Canada, SSPE occurs in between four and 11 out of every 100,000 measles cases. Health officials say it strikes between seven and 11 years after an initial infection and the highest rates are among children who contract measles before the age of two. If I'm pregnant can I get the measles vaccine? No, the measles vaccine is not recommended to be administered to people who are already pregnant. "If you want to take the measles vaccine, it has to be before you're pregnant," Choo said. That's because the measles vaccine contains a live strain that is a weakened form of the virus, which is not recommended during pregnancy. Choo says that's because there is a theoretical risk that the measles virus contained in the vaccine can be passed to the baby. In contrast, vaccines that contain inactivated viruses can be given during pregnancy. The flu vaccine is one example. Is there treatment for pregnant people exposed to measles? If you're pregnant and you think you may have been exposed to measles, health officials advise you to contact your local health authority. They can determine if exposure occurred and direct patients to seek appropriate care without contributing to further spread. If measles exposure is confirmed, Choo says there is an injectable medication option called IVIg. Depending on when the exposure occurred, the medication may be used to help protect against infection or reduce severity of the illness. However, health officials and doctors agree that the best way to protect against measles is immunization. "The most important recommendation or advice I can give … is to make sure you're up to date with all the immunization if you're starting that journey of becoming pregnant," Wong said.
Yahoo
6 days ago
- Yahoo
Canada infant born with measles from unvaccinated mother dies
A Canadian infant who was born prematurely and had measles has died, officials said Thursday without confirming a cause of death, raising heightened concern about the virus's resurgence. Canada has recorded 2,755 measles cases -- including 2,429 confirmed and 326 probable -- according to federal health data updated on June 2. The epicenter of the outbreak is the province of Ontario, where nearly 2,000 cases have been reported. Ontario's chief medical officer of health, Kieran Moore, said in a statement "the infant contracted the virus before birth from their mother, who had not received the measles, mumps and rubella (MMR) vaccine." "While measles may have been a contributing factor in both the premature birth and death, the infant also faced other serious medical complications unrelated to the virus," he added. In March, Moore said the outbreak was "disproportionately affecting some Mennonite, Amish, and other Anabaptist communities," partly due to lower rates of vaccination among those populations. If measles is confirmed as the cause of the infant's death, it would mark the first fatality linked to the current outbreak. After Ontario, the next hardest hit area is the western province of Alberta, with 632 confirmed cases, according to the federal data. Measles is a highly contagious respiratory virus spread through droplets when an infected person coughs, sneezes or simply breathes. Known for its characteristic rash, it poses a serious risk to unvaccinated individuals, including infants under 12 months who are not ordinarily eligible for vaccination, and those with weakened immune systems. It can lead to severe complications, including pneumonia, brain swelling, premature birth and in rare cases, death. Hundreds died each year from the virus in Canada before widespread immunization programs were introduced in the early 1970s. It was considered eradicated in 1998 but cases continue to occur due to spread from other countries. The United States is also confronting a significant measles resurgence, with a vaccine-skeptical Mennonite Christian community straddling the Texas–New Mexico border hit particularly hard. President Donald Trump's Health Secretary Robert F. Kennedy Jr. has undermined confidence in the (MMR) vaccine -- a highly effective shot he has falsely claimed is dangerous and contains fetal debris. amc/bs/sms
